Lv31
386 积分 2022-12-05 加入
Antibody-drug conjugates in cancer treatment: from molecular design to clinical implementation
4个月前
已关闭
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
1年前
已完结
Perioperative Nivolumab in Resectable Lung Cancer
1年前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
1年前
已完结